GFAP in health and disease.

By J. Middeldorp, E. Hol. Progress in neurobiology, 2011

1,029 citations recorded by the source corpus.

Subfields: Developmental Neuroscience, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/57e71eec4f9476dc3cd29367f6a0a1ac79b01cfd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Developmental Neuroscience

1. E. Hol
2. Bruce S. McEwen
3. M. Popoli
4. G. Sanacora
5. M. Pekny
6. J. Wingfield
7. R. Duman
8. M. Sofroniew

In Molecular Biology

1. Bruce S. McEwen
2. A. Green
3. A. Petzold
4. M. Pekny

Citations in the corpus

• Blood GFAP as an emerging biomarker in brain and spinal cord disorders (2022, background): “(2018)25 Simoa (singleplex) RRMS+ (18) nsa Higher in PMS than in RRMS (P 0.05) ns (8.8”
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission (2011, background): “Classically, GFAP has been used as a marker for mature astrocytes, but more recent studies that highlight the complex relationship between GFAP expression and various astrocytic functions suggest that the expression may be heavily physiologically regulate”
• Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. (2015, background): “GFAP has been implicated to play a role, for example, in cell migration and motility, in anchoring the glutamate transporter GLAST/EAAT1 in the membrane, and in mitosis [1].”